Protea Fund - Sectoral Biotech Opportunities Fund Class IF H Fonds
8,58
CHF
-0,12
CHF
-1,38
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 9,83% |
| Amgen Inc | US0311621009 | 6,72% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 6,55% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 6,09% |
| AstraZeneca PLC ADR | US0463531089 | 3,96% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,93% |
| argenx SE ADR | US04016X1019 | 3,44% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,56% |
| Sarepta Therapeutics Inc | US8036071004 | 2,52% |
| Biogen Inc | US09062X1037 | 2,43% |
| Sonstige | 51,99% |